Viemed Healthcare Inc. (VMD)
undefined
undefined%
At close: undefined
8.74
0.23%
After-hours Dec 13, 2024, 04:00 PM EST

Company Description

Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment (DME) and post-acute respiratory healthcare services to patients in the United States.

It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.

The company also leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), percussion vests, oxygen concentrator units, and other small respiratory equipment; and sells and rents DME and patient medical services.

In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management related solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines.

Further, the company offers in home sleep apnea testing services.

Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.

Viemed Healthcare Inc.
Viemed Healthcare Inc. logo
Country United States
IPO Date Aug 9, 2019
Industry Medical - Devices
Sector Healthcare
Employees 1,142
CEO Casey Hoyt

Contact Details

Address:
625 East Kaliste Saloom Road
Lafayette, Louisiana
United States
Website https://www.viemed.com

Stock Details

Ticker Symbol VMD
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001729149
CUSIP Number 92663R105
ISIN Number CA92663R1055
Employer ID 00-0000000
SIC Code 8090

Key Executives

Name Position
Casey Hoyt Chief Executive Officer & Director
Jeremy Trahan EVice President, Chief Legal Officer & Corporate Secretary
Trae Paul Fitzgerald Chief Financial Officer
William Todd Zehnder Chief Operating Officer & Director
Dr. William Dana Frazier M.D. Chief Medical Officer & Director
Jerome Richard Cambre II Vice President of Sales
Michael Freeman Chief Business Development Officer

Latest SEC Filings

Date Type Title
Nov 26, 2024 4 Filing
Nov 21, 2024 4 Filing
Nov 14, 2024 SCHEDULE 13G/A [Amend] Filing
Nov 13, 2024 4 Filing
Nov 13, 2024 4 Filing
Nov 13, 2024 SCHEDULE 13G/A [Amend] Filing
Nov 12, 2024 8-K Current Report
Nov 08, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Nov 06, 2024 10-Q Quarterly Report
Nov 06, 2024 8-K Current Report